If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 319.30
Bid: 319.10
Ask: 319.30
Change: 1.50 (0.47%)
Spread: 0.20 (0.063%)
Open: 318.10
High: 319.70
Low: 317.20
Prev. Close: 317.80
NWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

6 Feb 2024 09:30

RNS Number : 1830C
NatWest Group plc
06 February 2024

6 February 2024

NatWest Group plc

Directorate Change

NatWest Group plc ('NWG') announces the appointment of Geeta Gopalan as an independent non-executive director with effect from 1 July 2024.

Howard Davies, Chairman of NWG, said:

"I am delighted to welcome Geeta to NatWest Group. Geeta will be a valuable addition to the board, bringing substantial financial and banking expertise, combined with a strong track record as a plc non-executive director."

Geeta currently serves as a non-executive director of Virgin Money UK PLC*, Funding Circle plc, Intrum S.A., and as a Trustee of The Old Vic Theatre. She previously served as a non-executive director of Dechra Pharmaceuticals Ltd, Ultra Electronics Plc, Wizink Bank SA, and Vocalink. Geeta's biography is set out below.

*Stepping down on 30 June 2024.

There are no further matters requiring disclosure under Listing Rule 9.6.13.

For further information contact:

NatWest Group Investor Relations:

Claire Kane

Director, Investor Relations

+44 (0) 20 7672 1758

NatWest Group Media Relations:

+44 (0) 131 523 4205

LEI: 2138005O9XJIJN4JPN90

-------------------------------------------------

Geeta Gopalan Biography

Geeta Gopalan is currently a non-executive director of Virgin Money UK PLC*, serving as Risk Committee Chair; Intrum S.A, Europe's largest credit investment and collections company; Funding Circle plc - the largest fintech platform for SME lending in the UK, serving as Senior Independent Director and Audit Committee Chair; and as Trustee and Finance Committee Chair at The Old Vic Theatre.

Geeta's previous non-executive directorships include Dechra Pharmaceuticals Ltd, a leading FTSE 150 veterinary pharmaceuticals company, serving as Remuneration Committee Chair; Ultra Electronics Plc, a highly specialised software company that supply solutions for defence, transport and aerospace; Wizink Bank SA, a private equity owned digital bank in Spain; Vocalink, the operator for the UK national payments infrastructure; Trustee Pilotlight, an enterprise focused on bringing business skills to the third sector; and as Vice-Chair and Member of the England Committee Big Lottery Fund, which is the largest non-government funder of community development in the UK and one of the largest globally.

Geeta has spent over 20 years in various executive roles across banking and fintechs. Geeta is also a Qualified Chartered Accountant (Chartered Accountants Institute, India).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOAKQLBBZLLLBBE
Date   Source Headline
31st Jan 20245:14 pmRNSTotal Voting Rights
29th Jan 20245:22 pmRNSTransaction in Own Shares
25th Jan 20245:21 pmRNSTransaction in Own Shares
23rd Jan 20245:04 pmRNSTransaction in Own Shares
22nd Jan 20249:21 amRNSHolding(s) in Company
19th Jan 20245:08 pmRNSTransaction in Own Shares
18th Jan 20245:39 pmRNSTransaction in Own Shares
17th Jan 20245:42 pmRNSTransaction in Own Shares
16th Jan 20245:30 pmRNSTransaction in Own Shares
15th Jan 20245:58 pmRNSTransaction in Own Shares
12th Jan 20245:02 pmRNSTransaction in Own Shares
11th Jan 20245:13 pmRNSTransaction in Own Shares
10th Jan 20245:28 pmRNSTransaction in Own Shares
9th Jan 20245:04 pmRNSTransaction in Own Shares
8th Jan 20245:18 pmRNSTransaction in Own Shares
5th Jan 20245:24 pmRNSTransaction in Own Shares
4th Jan 20245:09 pmRNSTransaction in Own Shares
3rd Jan 20245:39 pmRNSTransaction in Own Shares
3rd Jan 20244:00 pmRNSDirector/PDMR Shareholding
3rd Jan 202410:38 amRNSHolding(s) in Company
2nd Jan 20245:24 pmRNSTransaction in Own Shares
29th Dec 202312:47 pmRNSTotal Voting Rights
29th Dec 202310:30 amRNSDirector/PDMR Shareholding
28th Dec 20235:37 pmRNSTransaction in Own Shares
27th Dec 20235:18 pmRNSTransaction in Own Shares
22nd Dec 20231:27 pmRNSTransaction in Own Shares
21st Dec 20235:23 pmRNSTransaction in Own Shares
20th Dec 20235:35 pmRNSTransaction in Own Shares
19th Dec 20235:33 pmRNSTransaction in Own Shares
19th Dec 20233:00 pmRNSDirector/PDMR Shareholding
18th Dec 20235:31 pmRNSTransaction in Own Shares
15th Dec 20235:25 pmRNSTransaction in Own Shares
15th Dec 20239:00 amRNSKey findings from Phase 2 of Travers Smith review
13th Dec 20235:32 pmRNSTransaction in Own Shares
12th Dec 20235:29 pmRNSTransaction in Own Shares
11th Dec 20239:38 amRNSHolding(s) in Company
8th Dec 20239:46 amRNSPublication of a Prospectus
7th Dec 20235:18 pmRNSTransaction in Own Shares
6th Dec 20235:30 pmRNSTransaction in Own Shares
5th Dec 20235:07 pmRNSTransaction in Own Shares
4th Dec 20235:12 pmRNSTransaction in Own Shares
1st Dec 20235:41 pmRNSTransaction in Own Shares
1st Dec 20239:52 amRNSTotal Voting Rights
29th Nov 20235:57 pmRNSTransaction in Own Shares
28th Nov 20235:31 pmRNSTransaction in Own Shares
27th Nov 20235:35 pmRNSTransaction in Own Shares
24th Nov 20235:34 pmRNSTransaction in Own Shares
23rd Nov 20235:27 pmRNSTransaction in Own Shares
23rd Nov 20233:39 pmRNSDividend Declaration
22nd Nov 20235:39 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.